Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	45.86	-57.61	-106.41
Graham Fair Price	41.42	1.28	0.90
PEG	-66.09	< 0.005	0.03
Price/Book	-9.37	-0.27	-0.25
Price/Cash Flow	45.31	-9.01	-16.46
Prices/Earnings	45.31	-0.99	-1.80
Price/Sales	-45.31	0.49	0.90
Price/FCF	45.31	-9.01	-16.46
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	< 0.005	< 0.005
Operating Margin	0.00	-0.04	-0.04
ROA	-100.00	-0.16	-0.08
ROE	0.03	0.07	100.00
ROIC	-0.76	0.44	-42.54
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.06	0.21	-69.73
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.74	-1.00	35.46
EPS QOQ	0.62	-1.00	61.28
FCF QOQ	-1.80	-1.00	44.39
Revenue QOQ	0.07	1.00	1368.70
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	< 0.005	< 0.005	-50.00
Days Sales Outstanding (DSO)	64.84	32.42	-50.00
Inventory Turnover	37831500.00	75663000.00	100.00
Debt/Capitalization	69.07	-18.56	-73.14
Quick Ratio	0.28	0.28	< 0.005
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	-1.03	-1.03	< 0.005
Cash	0.12	0.12	< 0.005
Capex	0.00	0.00	0.00
Free Cash Flow	-0.02	-0.03	-99.98
Revenue	0.28	0.57	100.00
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.39	0.39	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-83.23	-43.35	47.91
Naive Interpretation	Member

06 - Financial Health · Bad

Rating